196 related articles for article (PubMed ID: 23506477)
1. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
Malla P; Kumar R; Kumar M
Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
[TBL] [Abstract][Full Text] [Related]
2. Cheminformatics based 3D-QSAR study on a series of 1,2-naphthoquinone derivatives as PTP 1B inhibitors.
Pahwa P; Papreja M
Acta Pol Pharm; 2012; 69(3):535-43. PubMed ID: 22594268
[TBL] [Abstract][Full Text] [Related]
3. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
Sindhu T; Srinivasan P
J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
[TBL] [Abstract][Full Text] [Related]
5. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
[TBL] [Abstract][Full Text] [Related]
7. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
8. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
13. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
14. Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors.
Taha MO; AlDamen MA
J Med Chem; 2005 Dec; 48(25):8016-34. PubMed ID: 16335926
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
[TBL] [Abstract][Full Text] [Related]
16. Calix[4]arene methylenebisphosphonic acids as inhibitors of protein tyrosine phosphatase 1B.
Trush VV; Cherenok SO; Tanchuk VY; Kukhar VP; Kalchenko VI; Vovk AI
Bioorg Med Chem Lett; 2013 Oct; 23(20):5619-23. PubMed ID: 24012179
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.
Tripuraneni NS; Azam MA
J Mol Model; 2015 Nov; 21(11):289. PubMed ID: 26499496
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.
Ma Y; Sun SX; Cheng XC; Wang SQ; Dong WL; Wang RL; Xu WR
Chem Biol Drug Des; 2013 Nov; 82(5):595-602. PubMed ID: 23848232
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
